These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31014402)
21. Human parvovirus B19 infection in children: uncommon clinical presentations. Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336 [TBL] [Abstract][Full Text] [Related]
22. Major Complication Following Kawasaki Disease in an Infant-The Development of Apical Infarction and Aneurysm Formation. Menahem S; Lefkovits J Children (Basel); 2021 Oct; 8(11):. PubMed ID: 34828694 [TBL] [Abstract][Full Text] [Related]
23. Kawasaki Disease in the neonate: case report and literature review. Altammar F; Lang B Pediatr Rheumatol Online J; 2018 Jul; 16(1):43. PubMed ID: 29970110 [TBL] [Abstract][Full Text] [Related]
24. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome. Kossiva L; Karanassios E; Papadopoulos G; Karavanaki K Cardiol Young; 2012 Aug; 22(4):461-5. PubMed ID: 21933460 [TBL] [Abstract][Full Text] [Related]
26. High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. Shafferman A; Birmingham JD; Cron RQ Pediatr Rheumatol Online J; 2014; 12():26. PubMed ID: 25045337 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine for the treatment of multisystem inflammatory syndrome in children with coronary artery aneurysms. Hiraoka T; Tsuge M; Kondo Y BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680277 [TBL] [Abstract][Full Text] [Related]
28. Kawasaki Disease Shock Syndrome Presented with Giant Coronary Artery Dilatation - Presentation of Two Cases and a Literature Review. Bejiqi R; Pajaziti N; Agushi S Acta Inform Med; 2022 Sep; 30(3):253-256. PubMed ID: 36311151 [TBL] [Abstract][Full Text] [Related]
29. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805 [TBL] [Abstract][Full Text] [Related]
30. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease. Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297 [TBL] [Abstract][Full Text] [Related]
35. Kawasaki disease presenting with hepatitis and prolonged fever: report of one case. Chen WT; Huang SR; Wang JK Acta Paediatr Taiwan; 2003; 44(3):174-6. PubMed ID: 14521027 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment. Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146 [TBL] [Abstract][Full Text] [Related]
37. A case of atypical Kawasaki disease with giant coronary artery aneurysm containing thrombus. Micallef ES; Attard MS; Grech V Images Paediatr Cardiol; 2016; 18(3):9-15. PubMed ID: 28405208 [TBL] [Abstract][Full Text] [Related]
38. Clinical spectrum of Kawasaki disease in infants. Tseng CF; Fu YC; Fu LS; Betau H; Chi CS Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):168-73. PubMed ID: 11458622 [TBL] [Abstract][Full Text] [Related]
39. Cost-effective use of echocardiography in children with Kawasaki disease. Scott JS; Ettedgui JA; Neches WH Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583 [TBL] [Abstract][Full Text] [Related]
40. Complete recovery of a patient with cardiogenic shock due to parvovirus B19 fulminant myocarditis after treatment with extracorporeal membrane oxygenation and intravenous immunoglobulin. Drwiła R; Rubiś P; Kapelak B; Rudnicka-Sosin L; Pankuweit S; Gackowski A Pol Arch Med Wewn; 2015; 125(3):199-201. PubMed ID: 25666442 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]